Literature DB >> 20224536

Subfascial endoscopic perforator surgery ameliorates the symptoms of chronic venous ulcer (C6) patients.

A T Kurdal1, M Cerrahoglu, I Iskesen, M Eserdag, H Sirin.   

Abstract

AIM: Chronic venous insufficiency and the development of venous ulceration, as a result of this condition affects quality of life. In order to avoid skin changes and allow for quick remedy, subfacial endoscopic perforator surgery (SEPS) has been suggested and gained some popularity. The purpose of this study was to assess the healing rate of venous ulcers in patients undergoing SEPS.
METHODS: The SEPS procedure by using two ports was applied in 20 patients with active venous ulceration (CEAP-C6). The results were evaluated by Doppler findings, Venous Disability Score (VDS) and Venous Clinical Severity Score (VCSS) before and after the operation. Patients with prior deep vein thrombosis were excluded from this study.
RESULTS: The ulcers healed in all patients. Significant clinical improvement according to VDS and VCSS values was obtained in all patients after the procedures. There was no mortality or any other major complication during the follow up period.
CONCLUSION: The advantages of using two-port, video-controlled SEPS procedure may provide freedom from the skin complications that can be seen after Linton operation with quick and sustainable ulcer healing.

Entities:  

Mesh:

Year:  2010        PMID: 20224536

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  2 in total

1.  Three-dimensional CT Venography: A Diagnostic Modality for the Preoperative Assessment of Patients with Varicose Veins.

Authors:  Katsutoshi Sato; Kazumasa Orihashi; Shinya Takahashi; Taiichi Takasaki; Tatsuya Kurosaki; Katsuhiko Imai; Minoru Ishifuro; Taijiro Sueda
Journal:  Ann Vasc Dis       Date:  2011-07-29

2.  Role of Subfascial Endoscopic Perforator Surgery (SEPS) in Management of Perforator Incompetence in Varicose Veins : A Prospective Randomised Study.

Authors:  M G Vashist; Vijay Malik; Nitin Singhal
Journal:  Indian J Surg       Date:  2012-07-05       Impact factor: 0.656

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.